SOLID TUMOR CANCER
Clinical trials for SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First test of new cancer pill targets advanced tumors
Disease control CompletedThis first-in-human study tested a new oral drug called RP903 in people with advanced cancers that had stopped responding to standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The study focused on specific cancers, including ovar…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients test experimental cancer drug in early safety trial
Disease control CompletedThis first-in-human study tested the safety of a new cancer drug called DF6215, both alone and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors that couldn't be removed by surgery, had returned, or had spread. The main goals were to fi…
Matched conditions: SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Dragonfly Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New generic cancer drug tested against original
Disease control CompletedThis study tested if a new, potentially cheaper generic version of the cancer drug Lonsurf works the same way in the body as the original brand-name drug. It involved 76 Chinese adults with solid tumors, checking how the drug was absorbed when taken with or without food. The goal…
Matched conditions: SOLID TUMOR CANCER
Phase: NA • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC